Phaos Technology Holdings (Cayman) (POAS) Non-Current Assets (2024 - 2025)
Phaos Technology Holdings (Cayman)'s (POAS) quarterly Non-Current Assets came in at $200741.0 in Q4 2025, down 35.87% on a QoQ basis from $313008.6 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Non-Current Assets (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Non-Current Assets data on file, last reported at $200741.0 in Q4 2025.
- Quarterly Non-Current Assets changed N/A year-over-year to $200741.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $200741.0 (changed N/A YoY) and the FY2025 annual result came in at $313295.3, down 6.53% from the prior year.
- Non-Current Assets retreated to $200741.0 in Q4 2025, from $313008.6 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $335197.3 in Q2 2024 to a low of $200741.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 84.70 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 33.51 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 68.24 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 37.24 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 7.05 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 2.37 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 26.75 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 20.19 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 8.29 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 4.13 Mn | 4.08 Mn | - | 200,740.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 200,740.96 |
| Apr 30, 2025 | 313,008.61 |
| Apr 30, 2024 | 335,197.34 |